Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05997095 PoEMS — Post-operative Electrical Muscle Stimulation to Stimulate Muscl… |
PoEMS — Post-operative Electrical… | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Nottingham | United Kingdom · University of Nottingham, Nottingham… | 2023-05-22 → 2025-12-28 | Ouvrir |
| NCT06375629 ES-HIFU, Prospective Data Collection of Patients Treated With Partial G… |
FocalOne | Cancer | À vérifier | TERMINATED | En attente / non publié | EDAP TMS S.A. | Spain · Hospital Consorcio General Universitario de V… | 2023-04-20 → 2025-03-14 | Ouvrir |
| NCT02248389 HIFU-KIDNEY — Evaluation of a Laparoscopic High Intensity Focused Ultra… |
Sonatherm 600i ablation system | Cancer | Phase 1 | COMPLETED | En attente / non publié | Indiana University | United States · IU Health University Hospital, Indian… | 2014-09-04 → 2015-06-08 | Ouvrir |
| NCT04123535 HIFU-UPS — Focused Ultrasound to Promote Immune Responses for Undiffere… |
ExAblate 2000/2100 Magnetic Reson… | Cancer | Non applicable | TERMINATED | En attente / non publié | Matthew Bucknor | United States · University of California, San Francis… | 2020-01-23 → 2026-04-30 | Ouvrir |
| NCT03844399 (3D) Ultrasound Imaging Liver and Kidney |
Ablation | Cancer | À vérifier | RECRUITING | En attente / non publié | Western University, Canada | Canada · Victoria Hospital, London, Canada | 2020-10-03 → 2027-02 | Ouvrir |
| NCT03613298 Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endome… |
HIFU (Focal One®) | Cancer | Non applicable | COMPLETED | En attente / non publié | EDAP TMS S.A. | France · Hôpital de la Croix Rousse, Lyon, France | 2015-09-21 → 2019-05 | Ouvrir |
| NCT05512663 Safety and Efficacy Evaluation of Transperineal Irreversible Electropor… |
Irreversible Electroporation (IRE) | Cancer | Non applicable | UNKNOWN | En attente / non publié | Jewish General Hospital | Non communiqué | 2022-09 → 2024-09 | Ouvrir |
| NCT07572136 Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Pa… |
TSLPR-CART | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-08-19 → 2032-06-30 | Ouvrir |
| NCT07766252 CCHW-delivered CFH-based Cancer Prevention Program Among Chinese Americ… |
CCHW-delivered CFH-based Cancer P… | Cancer | Non applicable | COMPLETED | En attente / non publié | Texas A&M University | United States · Texas A&M University, College Station… | 2019-12-01 → 2020-12-31 | Ouvrir |
| NCT06743555 SAVED LUNG — Surgery After Verifying Existing Disease in Locally Advanc… |
Standard-of-care surgery | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Centre hospitalier de l'Universit… | Canada · Centre Hospitalier de l'Universite de Montre… | 2026-10-01 → 2032-02 | Ouvrir |
| NCT05691478 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy i… |
Bone Scan | Cancer | Phase 2/3 | SUSPENDED | En attente / non publié | National Cancer Institute (NCI) | United States, Australia, Canada, New Zealand · Adven… | 2023-03-03 → 2030-03-20 | Ouvrir |
| NCT07388524 Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery … |
Atezolizumab | Cancer | Phase 3 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Beebe Health Campus, Rehoboth Beach, … | 2027-03-02 → 2032-09-30 | Ouvrir |
| NCT07281417 Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment… |
Biopsy Procedure | Cancer | Phase 2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Emory University Hospital Midtown, At… | 2026-11-24 → 2030-12-16 | Ouvrir |
| NCT07634471 A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lym… |
MK-1045 | Cancer | Phase 2/3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Israel, Spain, Taiwan, Turk… | 2026-06-22 → 2035-07-23 | Ouvrir |
| NCT06406465 A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Tox… |
Belinostat | Cancer | Phase 2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-08-19 → 2028-07-30 | Ouvrir |
| NCT05904899 An Evaluation of the Implementation of the Care and Monitoring at Home … |
An Evaluation of the Implementati… | Cancer | À vérifier | SUSPENDED | En attente / non publié | M.D. Anderson Cancer Center | United States · MD Anderson Cancer Center, Houston, U… | 2023-08-01 → 2026-12-31 | Ouvrir |
| NCT07733908 Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Pros… |
Effectiveness of Posluma PET Scan… | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Aditya Bagrodia | Non communiqué | 2026-08 → 2030-07 | Ouvrir |
| NCT03436485 CYPIDES — Safety and Pharmacokinetics of ODM-208 in Patients With Metas… |
ODM-208 | Cancer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Orion Corporation, Orion Pharma | United States, Finland, France, United Kingdom · Cent… | 2018-03-19 → 2026-10-31 | Ouvrir |
| NCT06050252 Testing the Combination of the Anticancer Drug Durvalumab With Chemothe… |
Biopsy Procedure | Cancer | Phase 2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Boston Medical Center, Boston, United… | 2024-07-10 → 2027-02-12 | Ouvrir |
| NCT05904782 Development of Brief Positive Affect Treatment (PAT) for Caregivers of … |
Development of Brief Positive Aff… | Cancer | À vérifier | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · The University of Texas M. D. Anderso… | 2025-08-29 → 2027-11-01 | Ouvrir |
| NCT05844865 Patient Derived Vascularized MicroTumor Model of Gastrointestinal Perit… |
Patient Derived Vascularized Micr… | Cancer | Non applicable | RECRUITING | En attente / non publié | University of California, Irvine | United States · Chao Family Comprehensive Cancer Cent… | 2023-05-04 → 2026-12 | Ouvrir |
| NCT06409065 Psycho-Spiritual Management for Patients With Advanced Cancer and Their… |
Psycho-Spiritual Management for P… | Cancer | Non applicable | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · MD Anderson, Houston, United States | 2024-01-09 → 2028-08-31 | Ouvrir |
| NCT06875310 A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo P… |
Adagrasib | Cancer | Phase 3 | RECRUITING | En attente / non publié | Mirati Therapeutics Inc. | United States, Argentina, Australia, Austria, Belgium… | 2025-04-24 → 2032-04-30 | Ouvrir |
| NCT04858958 FAVOUR — Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 I… |
Furmonertinib 160mg | Cancer | Phase 1 | COMPLETED | En attente / non publié | Allist Pharmaceuticals, Inc. | China · Shanghai Chest hospital, Shanghai, China | 2020-08-10 → 2025-06-25 | Ouvrir |
| NCT07764887 Impacted Tooth Management and Osteoradionecrosis Risk in NPC |
Prophylactic Impacted Tooth Extra… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | First Affiliated Hospital of Guan… | China · Affiliated Hospital of Youjiang Medical Unive… | 2026-08-30 → 2032-11-30 | Ouvrir |